Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;83:747-755

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peduzzi, P.
Right arrow Articles by Takaro, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peduzzi, P.
Right arrow Articles by Takaro, T.

Circulation, Vol 83, 747-755, Copyright © 1991 by American Heart Association


ARTICLES

Ten-year incidence of myocardial infarction and prognosis after infarction. Department of Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery

P Peduzzi, K Detre, ML Murphy, J Thomsen, H Hultgren and T Takaro
VA Medical Center, West Haven, CT 06516.

BACKGROUND. The 10-year incidence of myocardial infarction (fatal and nonfatal) and the prognosis after infarction were evaluated in 686 patients with stable angina who were randomly assigned to medical or surgical treatment in the Veterans Administration Cooperative Study of Coronary Artery Bypass Surgery. METHODS AND RESULTS. Myocardial infarction was defined by either new Q wave findings or clinical symptoms compatible with myocardial infarction accompanied by serum enzyme elevations with or without electrocardiographic findings. Treatment comparisons were made according to original treatment assignment; 35% of the medical cohort had bypass surgery during the 10- year follow-up period. The overall cumulative infarction rate was somewhat higher in patients assigned to surgery (36%) than in medical patients (31%) (p = 0.13) due to perioperative infarctions (13%) and an accelerated infarction rate after the fifth year of follow-up (average, 2.4%/yr in the surgical group versus 1.4%/yr in the medical group). The 10-year cumulative incidence of death or myocardial infarction was also higher in surgical (54%) than in medical (49%) patients (p = 0.20). According to the Cox model, the estimated risk of death after infarction was 59% lower in surgical than in medical patients (p less than 0.0001). The reduction in postinfarction mortality with surgery was most striking in the first month after the event: 99% in the first month (p less than 0.0001) and 49% subsequently (p less than 0.0001). The estimated risk of death in the absence of infarction was nearly identical regardless of treatment (p = 0.75). Exclusion of perioperative infarctions did not alter the findings. CONCLUSIONS. Although surgery does not reduce the incidence of myocardial infarction overall, it does reduce the risk of mortality after infarction, particularly in the first 30 days after the event (fatal infarctions).


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Wittlinger, O. Dzemali, I. Martinovic, and A. Moritz
Assessment of coronary artery bypass grafts patency with different magnetic resonance technologies.
Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 436 - 442.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G Montalescot, H R Andersen, D Antoniucci, A Betriu, M J de Boer, L Grip, F J Neumann, and M T Rothman
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction
Heart, June 1, 2004; 90(6): e37 - e37.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K.-H. Mak and D. P. Faxon
Clinical studies on coronary revascularization in patients with type 2 diabetes
Eur. Heart J., June 2, 2003; 24(12): 1087 - 1103.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. G F Cleland, J. John, J. Dhawan, and A. Clark
What is the optimal medical management of ischaemic heart failure?
Br. Med. Bull., October 1, 2001; 59(1): 135 - 158.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. M. Detre, M. S. Lombardero, M. M. Brooks, R. M. Hardison, R. Holubkov, G. Sopko, R. L. Frye, B. R. Chaitman, and The Bypass Angioplasty Revascularization Investiga
The Effect of Previous Coronary-Artery Bypass Surgery on the Prognosis of Patients with Diabetes Who Have Acute Myocardial Infarction
N. Engl. J. Med., April 6, 2000; 342(14): 989 - 997.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. B. Investigators
Influence of Diabetes on 5-Year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients With Multivessel Disease : The Bypass Angioplasty Revascularization Investigation (BARI)
Circulation, September 16, 1997; 96(6): 1761 - 1769.
[Abstract] [Full Text]